Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Ordinary shares, par value $0.000174
- Shares outstanding
- 62,516,710
- Total 13F shares
- 14,969,473
- Share change
- -2,738,997
- Total reported value
- $13,034,000
- Price per share
- $0.87
- Number of holders
- 26
- Value change
- -$10,410,998
- Number of buys
- 15
- Number of sells
- 12
Report period
Q2 2022
Institutions
26
Top holders
10
CNTB full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
11%
|
6,991,003
|
$21,113,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
3.7%
|
2,283,269
|
$6,894,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.6%
|
2,236,392
|
$6,755,000 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.6%
|
1,599,826
|
$4,807,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
1,437,500
|
$4,341,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.1%
|
677,859
|
$2,047,000 | — | 31 Mar 2022 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.96%
|
597,678
|
$1,805,000 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.71%
|
446,564
|
$1,349,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.5%
|
313,732
|
$947,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
296,136
|
$894,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.45%
|
279,921
|
$845,000 | — | 31 Mar 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.36%
|
227,759
|
$688,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
77,851
|
$235,000 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.1%
|
60,449
|
$183,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.07%
|
43,871
|
$132,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
23,500
|
$71,000 | — | 31 Mar 2022 | |
| CSS LLC/IL |
13F
|
Company |
0.03%
|
20,000
|
$60,000 | — | 31 Mar 2022 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.03%
|
19,588
|
$17,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
19,281
|
$58,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
19,032
|
$57,000 | — | 31 Mar 2022 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.03%
|
18,062
|
$55,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,806
|
$27,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
3,920
|
$12,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,861
|
$6,000 | — | 31 Mar 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,255
|
$3,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,239
|
$4,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,053
|
$3,000 | — | 31 Mar 2022 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) as of Q2 2022
As of 30 Jun 2022,
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,969,473 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., Kynam Capital Management, LP, JANUS HENDERSON GROUP PLC, Ikarian Capital, LLC, UBS OCONNOR LLC, Sio Capital Management, LLC, CITADEL ADVISORS LLC, and CITIGROUP INC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
26
Q2 2022 holders
26
Holder diff
0
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.